Subcutaneous integrin inhibitors may provide more treatment options for patients with moderate-to-severe ulcerative colitis
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
Korean Association for the Study of Intestinal Diseases
2019-07-01
|
Series: | Intestinal Research |
Online Access: | http://www.irjournal.org/upload/pdf/ir-2019-00070.pdf |